Skip to main content
. 2019 May 28;11(4):355–366. doi: 10.1177/1941738119834972

Figure 1.

Figure 1.

Study flow diagram depicting the number of studies at each stage of the systematic review, with reasons for exclusion. In the end, 78 RCTs that compared a platelet-rich product to a control in patients with an orthopaedic injury were included for analysis (n = 5308 randomized patients).